Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIF-PHI (Roxadustat) vs Epoetin Alfa in Incident Dialysis Anemia
NCT04134026Phase 4Unknown
- Sponsor
- The Second Xiangya Hospital
- Start
- Oct 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of roxadustat in anemia, sponsored by The Second Xiangya Hospital. Status: unknown.
02
Drugs
roxadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT04134026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04134026.